Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB

Tubercle and Lung Disease

Volumn 78, Issue 5-6, 1997, Pages 247-255

  Rich, E A ^a,d   Torres, M ^b   Sada, E ^b   Finegan, C K ^a   Hamilton, B D ^a   Toossi, Z ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE;

ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IMMUNOBLOTTING; LUNG ALVEOLUS MACROPHAGE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

EID: 0031400122     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8479(97)90005-8     Document Type: Article

References (36)

1. Hirsch C S, Ellner J J, Russell D G, Rich E A. Complement receptor 4-mediated uptake and tumor necrosis factor-mediated growth inhibition of Mycobacterium tuberculosis in human alveolar macrophages. J Immunol 1994; 152: 743-753.
2. Rich E A, Panuska J R, Wallis R S, Wolf C B, Ellner J J. Dyscoordinate expression of tumor necrosis factor-alpha by human blood monocytes and alveolar macrophages. American Review of Respiratory Disease 1989; 139: 1010-1016.
3. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
4. Bredt D S, Snyder S H. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 1994; 63: 175-195.
5. Flesch IE, Kaufmann S H. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect Immun 1991; 59: 3213-3219.
6. Chan J J, Flynn K J, Trebold D K, Dalton T A, Stewart T A, Bloom B R. An essential role for Interferon gamma in resistance to mycobacterium tuberculosis infection. J Exp Med 1993; 178: 2249-2254.
7. Chan J, Tanaka D, Caroll D, Flynn J, Bloom B R. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun 1995; 63: 736-740.
8. Greenberg S S, Xie J, Kolls J, Mason C, Didier P. Rapid reduction of mRNA for nitric oxide synthase II in rat alveolar macrophages by intratracheal administration of Mycobacterium tuberculosis and Mycobacterium avium. Proc Soc Exp Biol Med 1995; 209: 46-53.
9. Weinberg J B, Misukonis M A, Shami P J et al. Human mononuclear phagocytes inducible nitric oxide synthase (NOS) analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 1995; 86: 1184-1195.
10. Scheemann M, Schoedon G, Hofer S, Blau N, Guerrero L, Schaffner A. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis 1993; 167: 1358-1363.
11. Denis M. Human monocytes/macrophages: NO or no NO? J Leukoc Biol 1994; 55: 682-684.
12. Padgett E L, Pruett S B. Evaluation of nitrite production by human monocyte-derived macrophages. Biochem Biophys Res Commun 1992; 186: 775-781.
13. Munoz-Fernandez M A, Fernandez M A, Fresno M. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism. Immunol Lett 1992; 33: 35-40.
14. Hunt N C A, Goldin R D. Nitric oxide production by monocytes in alcoholic liver disease. J Hepatol 1992; 14: 146-150.
15. Pietraforte D, Tritarelli E, Testa U, Minetti M. gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J Leukoc Biol 1994; 55: 175-182.
16. Zembala M, Siedlar M, Marcinkiewicz J, Pryjma J. Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide. Eur J Immunol 1994; 24: 435-439.
17. De Maria R, Cifone M G, Trotta R et al. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J Exp Med 1994; 180: 1999-2004.
18. Reiling N, Ulmer A J, Duchrow M, Ernst M, Flad H-D, Hauschildt S. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol 1994; 24: 1941-1944.
19. Kroncke K D, Fehsel K, Alsdorff L, Kolb-Bachofen V. Expression of inducible NO-synthase in human monocytes. Immunobiology 1994; 191: 267-268.
20. Peterson P K, Hu S, Anderson W R, Chao C C. Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain. J Infect Dis 1994; 170: 457-460.
21. Mautino G, Paul-Eugene N, Chanez P et al. Heterogeneous spontaneous and interleukin-4-induced nitric oxide production by human monocytes. J Leukoc Biol 1994; 56: 15-20.
22. Bukrinsky M I, Nottet H D L M, Schmidtmayerove N et al. Regulation of nitric oxide synthase activity in human immunodeficiency virus type-1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 1994; 181: 735-745.
23. Dumarey C H, Labrousse V, Rastogi N, Vargaftig B B, Bachelet M. Selective Mycobacterium avium-indaced production of nitric oxide by human monocyte-derived macrophages. J Leukoc Biol 1994; 56: 36-40.
24. Vouldoukis I, Riveros-Moreno V, Dugas B et al. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FcERI/CD23 surface antigen. Proc Natl Acad Sci USA 1995; 92: 7804-7808.
25. Sherman M P, Loro M L, Wong V Z, Tashkin D P. Cytokine- and Pneumocystis carinii-induced L-Arginine oxidation by murine and human pulmonary alveolar macrophages. J Protozool 1991; 38: 234S-236S.
26. Kobzik L, Bredt S, Lowenstein C J et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 1993; 9: 371-377.
27. Nozaki Y, Hasegawat Y, Ichiyama S, Nakashima I, Shimokata K. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect Immun 1997; 65: 3644-3647.
28. Nicholson S, da Gloria Bonecini-Almeida M, Lapa e Silva J R et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996; 183: 2293-2302.
29. Denis M. Tumor necrosis facor and granulocyte macrophagecolony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium. J Leukoc Biol 1991; 9: 380-387.
30. Bartholomew B. A rapid method for the assay of nitrate in urine using the nitrite reductase enzyme of Escherichia coli. Food Chem Toxicol 1984; 22: 541-543.
31. Geller D A, Lowenstein C J, Shapiro R A et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 1993; 90: 3491-3495.
32. Marietta M A. Nitric oxide synthase: aspects concerning structure and catalysis. Cell 1994; 78: 927-930.
33. Nathan C, Xie Q-W. Nitric oxide synthases: roles, tolls, and controls. Cell 78: 915-918.
34. Lyons C R. The role of nitric oxide in inflammation. Adv Immunol 1995: 60: 323-371.
35. Cameron M L, Granger D L, Weinberg J B, Kozumbo W J, Koren H S. Human alveolar and peritoneal macrophages mediate fungistasis independently of L-Arginine oxidation to nitrite or nitrate. American Review of Respiratory Disease 1990; 142: 1313-1319.
36. MacMicking A D, North RJ, La Course R, Mudgett J S, Shah S K, Nathan C F. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci 1997; 94: 5243-5248.